3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
1
Conditions
Ovarian Neoplasms
31
Peritoneal Neoplasms
28
Fallopian Tube Neoplasms
14
Stomach Neoplasms
13
Carcinoma, Ovarian Epithelial
13
Colorectal Neoplasms
11
Appendiceal Neoplasms
5
Neoplasm Metastasis
4
Uterine Neoplasms
3
Recurrence
3
Neoplasms
3
Uterine Cervical Neoplasms
2
Pseudomyxoma Peritonei
2
Pancreatic Neoplasms
2
Mesothelioma, Malignant
2
Mesothelioma
2
Colonic Neoplasms
2
Carcinoma
2
Sarcoma
1
Rhabdomyosarcoma
1
Rectal Neoplasms
1
Pleural Effusion
1
Peritoneal Diseases
1
Pelvic Neoplasms
1
Ovarian Epithelial Cancer Recurrent
1
Ovarian Cancer Recurrent
1
Liposarcoma
1
Krukenberg Tumor
1
Hyperthermia
1
Gastrointestinal Neoplasms
1
Interventions
liposomal doxorubicin
1
Trabectedin
1
Hyperthermic Intraperitoneal Chemotherapy
1
Docetaxel
1
Carboplatin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Ovarian Epithelial Cancer Recurrent
×
Hyperthermic Intraperitoneal Chemotherapy
×
Gynecologic
×
Clear all
NCT01376752
2026-05-20
CHIPOR
UNICANCER
Phase 3
Active not recruiting
415 enrolled